These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17932246)

  • 1. Small-molecule melanin-concentrating hormone-1 receptor antagonists require brain penetration for inhibition of food intake and reduction in body weight.
    Eric Hu X; Wos JA; Dowty ME; Suchanek PM; Ji W; Chambers JB; Benoit SC; Clegg DJ; Reizes O
    J Pharmacol Exp Ther; 2008 Jan; 324(1):206-13. PubMed ID: 17932246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiobesity effect of a melanin-concentrating hormone 1 receptor antagonist in diet-induced obese mice.
    Mashiko S; Ishihara A; Gomori A; Moriya R; Ito M; Iwaasa H; Matsuda M; Feng Y; Shen Z; Marsh DJ; Bednarek MA; MacNeil DJ; Kanatani A
    Endocrinology; 2005 Jul; 146(7):3080-6. PubMed ID: 15817671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 2-aminobenzimidazoles as potent melanin-concentrating hormone 1-receptor (MCH1R) antagonists.
    Moriya M; Kishino H; Sakuraba S; Sakamoto T; Suga T; Takahashi H; Suzuki T; Ito M; Ito J; Moriya R; Takenaga N; Iwaasa H; Ishihara A; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3568-72. PubMed ID: 19457661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a selective melanin-concentrating hormone 1 receptor antagonist on food intake and energy homeostasis in diet-induced obese mice.
    Kowalski TJ; Spar BD; Weig B; Farley C; Cook J; Ghibaudi L; Fried S; O'Neill K; Del Vecchio RA; McBriar M; Guzik H; Clader J; Hawes BE; Hwa J
    Eur J Pharmacol; 2006 Mar; 535(1-3):182-91. PubMed ID: 16540104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Kameda M; Ando M; Miyazoe H; Sekino E; Ito S; Masutani K; Kamijo K; Takezawa A; Moriya M; Ito M; Ito J; Nakase K; Matsushita H; Ishihara A; Takenaga N; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5339-45. PubMed ID: 19683441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the anti-obesity effects induced by a novel melanin-concentrating hormone 1-receptor antagonist in mice.
    Ito M; Ishihara A; Gomori A; Matsushita H; Ito M; Metzger JM; Marsh DJ; Haga Y; Iwaasa H; Tokita S; Takenaga N; Sato N; MacNeil DJ; Moriya M; Kanatani A
    Br J Pharmacol; 2010 Jan; 159(2):374-83. PubMed ID: 20015294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further insights into the neurobiology of melanin-concentrating hormone in energy and mood balances.
    Hervieu GJ
    Expert Opin Ther Targets; 2006 Apr; 10(2):211-29. PubMed ID: 16548771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent updates on the melanin-concentrating hormone (MCH) and its receptor system: lessons from MCH1R antagonists.
    Chung S; Parks GS; Lee C; Civelli O
    J Mol Neurosci; 2011 Jan; 43(1):115-21. PubMed ID: 20582487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
    McBriar MD; Guzik H; Shapiro S; Paruchova J; Xu R; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'neill K; Spar BD; Weig B; Weston DJ; Farley C; Cook J
    J Med Chem; 2006 Apr; 49(7):2294-310. PubMed ID: 16570926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
    Sasmal PK; Sasmal S; Rao PT; Venkatesham B; Roshaiah M; Abbineni C; Khanna I; Jadhav VP; Suresh J; Talwar R; Muzeeb S; Receveur JM; Frimurer TM; Rist Ø; Elster L; Högberg T
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5443-8. PubMed ID: 20724156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of central melanin-concentrating hormone 1 receptor alleviates steatohepatitis in mice.
    Ito M; Gomori A; Suzuki J; Tsujioka S; Sasaki M; Matsuda M; Bednarek MA; Ito M; Ishihara A; Iwaasa H; Macneil DJ; Kanatani A
    J Endocrinol; 2008 Aug; 198(2):309-15. PubMed ID: 18523032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute homeostatic responses to increased fat consumption in MCH1R knockout mice.
    Chung S; Wong T; Nagasaki H; Civelli O
    J Mol Neurosci; 2010 Nov; 42(3):459-63. PubMed ID: 20411353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism.
    Marsh DJ; Weingarth DT; Novi DE; Chen HY; Trumbauer ME; Chen AS; Guan XM; Jiang MM; Feng Y; Camacho RE; Shen Z; Frazier EG; Yu H; Metzger JM; Kuca SJ; Shearman LP; Gopal-Truter S; MacNeil DJ; Strack AM; MacIntyre DE; Van der Ploeg LH; Qian S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3240-5. PubMed ID: 11867747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.
    McBriar MD; Guzik H; Xu R; Paruchova J; Li S; Palani A; Clader JW; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar B; Weig B
    J Med Chem; 2005 Apr; 48(7):2274-7. PubMed ID: 15801820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models.
    Kawata Y; Okuda S; Hotta N; Igawa H; Takahashi M; Ikoma M; Kasai S; Ando A; Satomi Y; Nishida M; Nakayama M; Yamamoto S; Nagisa Y; Takekawa S
    Eur J Pharmacol; 2017 Feb; 796():45-53. PubMed ID: 27986627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression.
    Gehlert DR; Rasmussen K; Shaw J; Li X; Ardayfio P; Craft L; Coskun T; Zhang HY; Chen Y; Witkin JM
    J Pharmacol Exp Ther; 2009 May; 329(2):429-38. PubMed ID: 19182070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a novel potent melanin-concentrating hormone receptor 1 antagonist, AZD1979, on body weight homeostasis in mice and dogs.
    Ploj K; Benthem L; Kakol-Palm D; Gennemark P; Andersson L; Bjursell M; Börjesson J; Kärrberg L; Månsson M; Antonsson M; Johansson A; Iverson S; Carlsson B; Turnbull A; Lindén D
    Br J Pharmacol; 2016 Sep; 173(18):2739-51. PubMed ID: 27400775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-obesity effects of the combined administration of CB1 receptor antagonist rimonabant and melanin-concentrating hormone antagonist SNAP-94847 in diet-induced obese mice.
    Verty AN; Lockie SH; Stefanidis A; Oldfield BJ
    Int J Obes (Lond); 2013 Feb; 37(2):279-87. PubMed ID: 22473329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of tetralin ureas as potent melanin concentrating hormone 1 receptor antagonists.
    Guo T; Gu H; Hobbs DW; Busler DE; Rokosz LL
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1718-21. PubMed ID: 17251014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic effects of the MCH1R antagonist TPI 1361-17.
    Lee C; Parks GS; Civelli O
    J Mol Neurosci; 2011 Feb; 43(2):132-7. PubMed ID: 20635163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.